
India develops its own H5N1 vaccine amid fresh bird flu outbreaks
Developed by ICAR-NIHSAD, a single dose provides protection for up to six months, making it suitable for layer and breeder chickens
India has developed its first indigenous vaccine against H5N1 avian influenza, commonly known as bird flu, to strengthen its preparedness for outbreaks affecting poultry. Union Agriculture Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation at the ICAR-National Institute of High Security Animal Diseases (NIHSAD) in Bhopal on November 20.
Developed by ICAR-NIHSAD, the inactivated vaccine targets the H5N1 virus of clade 2.3.2.1a, which has been responsible for most bird flu outbreaks in chickens. According to the statement, a single dose provides protection for up to six months, making it suitable for layer and breeder chickens.
Bird flu outbreaks
The development comes amid fresh bird flu outbreaks in parts of the country, including Tamil Nadu and Andhra Pradesh, which have reported bird deaths and culling as part of containment measures.
Also read: H5N1 bird flu alert in India: crows, poultry die across states
In Tamil Nadu’s Cuddalore district, H5N1 infection was confirmed in November following sudden bird deaths at poultry farms. As of November 13, 35,647 birds had died in the affected zone. Authorities initiated culling within a one-kilometre radius of the affected premises, with around 40,000 chickens subsequently reported to have been culled. Poultry movement was also restricted.
Andhra Pradesh reported an outbreak in October in Anantapur district, including Siddarampuram village in Bukkarayasamudram mandal. The state government declared infected and surveillance zones and imposed restrictions on poultry movement.
H5N1 strain
Bird flu, or highly pathogenic avian influenza (HPAI), can cause severe disease and high mortality among poultry. Outbreaks often lead to large-scale culling, movement restrictions and trade disruptions, causing substantial losses to farmers. Since the disease was first detected in India in 2006, more than 500 combined outbreaks of the H5N1 and H5N8 subtypes have been reported.
Also read: Avian flu confirmed in Kerala's Alappuzha; nearly 6,000 birds to be culled
The government says the H5N1 clade 2.3.2.1a strain has also been detected in different animal species, including mammals, as well as in three human cases. The World Health Organization has reported 1,003 human cases of H5N1, including 479 deaths, across 25 countries since 2003.
Until now, no specific commercial vaccine has been available against the H5N1 virus of clade 2.3.2.1a. The indigenous vaccine is expected to add another tool to India’s efforts to control outbreaks, alongside surveillance, testing, biosecurity and culling.
